Wird geladen...
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States
BACKGROUND: The efficacy of bevacizumab (BEV) in elderly patients with glioblastoma remains unclear. We evaluated the effect of BEV on survival in this patient population using the Survival, Epidemiology, and End Results (SEER)-Medicare database. METHODS: This retrospective, cohort study analyzed SE...
Gespeichert in:
| Veröffentlicht in: | Neurooncol Pract |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655482/ https://ncbi.nlm.nih.gov/pubmed/31385957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npy001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|